Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
10.26
-0.21 (-2.01%)
At close: Aug 15, 2025, 3:59 PM
10.24
-0.15%
After-hours: Aug 15, 2025, 06:01 PM EDT
Phathom Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.66M | -35.83M | -36.66M | -36.55M | -34.84M |
Depreciation & Amortization | 172K | 177K | 193K | 191K | 197K | 214K | 185K | 121K | 123K | 146K | 168K | 175K | 149K | 128K | 135K | 130K | 131K | 125K |
Stock-Based Compensation | 8.27M | 5.54M | 6.69M | 5.63M | 6.1M | 5.63M | 24.58M | 6.14M | 7.25M | 7.05M | 6.66M | 5.82M | 5.88M | 5.78M | 4.34M | 4.42M | 4.24M | 3.82M |
Other Working Capital | n/a | 7.94M | -5.66M | 5.64M | -2.59M | 653K | 1.38M | -7M | 1.57M | -5.04M | -3.71M | 796K | -315K | -6.22M | -11.38M | -2.89M | 6.65M | -10.07M |
Other Non-Cash Items | 4.64M | 3.67M | 13.15M | 8.53M | 19.59M | 28.74M | 10.33M | 7.48M | 6.96M | 7.29M | 7.32M | 7.39M | 4.34M | 1.96M | 1.47M | 2.7M | 517K | 721K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | -9.04M | 7.65M | -626K | -7.02M | 676K | -2.41M | 4.43M | -16.34M | 208K | 2.69M | 14.83M | -12.3M | -11.54M | 345K | 3.3M | -19.59M |
Operating Cash Flow | -62.73M | -84.93M | -63.46M | -63.57M | -70.72M | -69.02M | -43.8M | -31.91M | -22.2M | -39.67M | -40.7M | -35.02M | -25.72M | -45.1M | -41.42M | -29.07M | -28.36M | -49.77M |
Capital Expenditures | n/a | n/a | -5K | 86K | -46K | -40K | -475K | -939K | -6K | -214K | -412K | -134K | -428K | -67K | -100K | -14K | -45K | -169K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -97K | -18K | n/a | -130K | n/a | -47K | -1.65M | n/a | n/a | n/a | -1.18M | n/a | n/a | -187K | -330K | n/a | n/a | -190K |
Investing Cash Flow | -97K | -18K | -5K | -44K | -46K | -40K | -475K | -939K | -6K | -214K | -412K | -134K | -428K | -67K | -100K | -14K | -45K | -169K |
Debt Repayment | n/a | n/a | 24.75M | n/a | 24.75M | 9.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.76M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 80K | n/a | 1.3M | 282K | 21K | n/a | 211.99M | 13K | 111K | n/a | -24.6M | n/a | 95.45M | n/a | 163K | 1.26M | 104K | 412K |
Financial Cash Flow | 80K | n/a | 26.05M | 122.06M | 24.77M | 9.9M | 211.99M | 13K | 141.5M | 14.07M | n/a | 24.6M | 95.45M | n/a | 163K | 44.03M | 104K | 412K |
Net Cash Flow | -62.75M | -84.95M | -37.41M | 58.44M | -45.99M | -59.16M | 167.72M | -32.84M | 119.3M | -25.81M | -40.95M | -10.55M | 69.3M | -45.17M | -41.36M | 14.95M | -28.3M | -49.52M |
Free Cash Flow | -62.73M | -84.95M | -63.46M | -63.49M | -70.77M | -69.06M | -44.27M | -32.85M | -22.21M | -39.88M | -41.11M | -35.15M | -26.14M | -45.17M | -41.52M | -29.08M | -28.41M | -49.93M |